GB1474852A - Tertiary alcohol stabilized e-series prostaglandins - Google Patents

Tertiary alcohol stabilized e-series prostaglandins

Info

Publication number
GB1474852A
GB1474852A GB1375075A GB1375075A GB1474852A GB 1474852 A GB1474852 A GB 1474852A GB 1375075 A GB1375075 A GB 1375075A GB 1375075 A GB1375075 A GB 1375075A GB 1474852 A GB1474852 A GB 1474852A
Authority
GB
United Kingdom
Prior art keywords
prostaglandin
series
tertiary alcohol
pge2
april
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1375075A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PFIZER
Pfizer Inc
Original Assignee
PFIZER
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PFIZER, Pfizer Inc filed Critical PFIZER
Publication of GB1474852A publication Critical patent/GB1474852A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GB1375075A 1974-04-19 1975-04-03 Tertiary alcohol stabilized e-series prostaglandins Expired GB1474852A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US462213A US3927197A (en) 1974-04-19 1974-04-19 Tertiary alcohol stabilized E-series prostaglandins

Publications (1)

Publication Number Publication Date
GB1474852A true GB1474852A (en) 1977-05-25

Family

ID=23835600

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1375075A Expired GB1474852A (en) 1974-04-19 1975-04-03 Tertiary alcohol stabilized e-series prostaglandins

Country Status (23)

Country Link
US (1) US3927197A (enExample)
JP (1) JPS5337408B2 (enExample)
AR (1) AR213271A1 (enExample)
AT (1) AT348130B (enExample)
AU (1) AU470631B2 (enExample)
BE (1) BE828065A (enExample)
BG (1) BG35326A3 (enExample)
CA (1) CA1034044A (enExample)
CS (1) CS191244B2 (enExample)
DD (1) DD119131A5 (enExample)
DE (1) DE2516105C3 (enExample)
DK (1) DK138161B (enExample)
ES (1) ES436613A1 (enExample)
FI (1) FI62220C (enExample)
FR (1) FR2267760B1 (enExample)
GB (1) GB1474852A (enExample)
HU (1) HU175405B (enExample)
IE (1) IE40829B1 (enExample)
IL (1) IL46994A (enExample)
LU (1) LU72320A1 (enExample)
NL (1) NL158384B (enExample)
PH (1) PH11697A (enExample)
SE (1) SE428528B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4197257A (en) * 1976-02-04 1980-04-08 The Upjohn Company 6-Keto prostaglandin derivatives
US4169895A (en) * 1976-09-28 1979-10-02 Pfizer Inc. Antisecretory 16,16-dimethyl-17-oxaprostaglandins
US4098805A (en) * 1977-04-11 1978-07-04 The Upjohn Company 9-deoxy-9-methylene-pgf-type amides
ZA831186B (en) * 1982-03-22 1983-11-30 Upjohn Ltd Gelled pge2/triacetin solutions
ZA837627B (en) * 1982-10-15 1984-06-27 Procter & Gamble Storage stable topical pharmaceutical composition containing low dielectric solvents
US5409911A (en) * 1992-09-11 1995-04-25 Merck & Co., Inc. Prostaglandin analog for treating osteoporosis
US5741523A (en) * 1993-10-27 1998-04-21 Pharmacia & Upjohn Company Stabilized prostaglandin E1
HN1996000101A (es) 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
US6121253A (en) * 1998-11-20 2000-09-19 Merck Frosst Canada & Co. Prostaglandin conjugates for treating or preventing bone disease
US20050203086A1 (en) * 2004-03-04 2005-09-15 Pfizer Inc. Methods of treatment using an EP2 selective receptor agonist
EP2155769B1 (en) 2007-05-04 2012-06-27 Katholieke Universiteit Leuven KU Leuven Research & Development Tissue degeneration protection
US9005183B2 (en) * 2007-05-16 2015-04-14 Health Knight, Llc System and method for treating erectile dysfunction
AT515356B1 (de) * 2014-01-30 2015-11-15 Gebro Holding Gmbh Stabile alkoholische Lösung von Alprostadil
US12589097B2 (en) 2018-02-21 2026-03-31 OrphAl Therapeutics Inc. Apilimod compositions and methods of use
US10751345B2 (en) 2018-02-21 2020-08-25 AI Therapeutics, Inc. Combination therapy with apilimod and glutamatergic agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3644638A (en) * 1970-08-24 1972-02-22 American Home Prod Compositions and methods for relieving bronchial spasm with prostanoic acids and esters
US3749800A (en) * 1971-11-01 1973-07-31 Upjohn Co Stable composition for dispensing pge2
US3833725A (en) * 1972-12-08 1974-09-03 Syntex Corp Dialkylated glycol compositions and medicament preparations containing same

Also Published As

Publication number Publication date
SE428528B (sv) 1983-07-11
IE40829B1 (en) 1979-08-29
FR2267760A1 (enExample) 1975-11-14
DK138161B (da) 1978-07-24
DK138161C (enExample) 1979-01-02
PH11697A (en) 1978-05-24
LU72320A1 (enExample) 1976-03-17
HU175405B (hu) 1980-07-28
JPS5337408B2 (enExample) 1978-10-09
AU470631B2 (en) 1976-03-25
CS191244B2 (en) 1979-06-29
AT348130B (de) 1979-01-25
US3927197A (en) 1975-12-16
NL158384B (nl) 1978-11-15
CA1034044A (en) 1978-07-04
AU7987775A (en) 1976-03-25
FI751108A7 (enExample) 1975-10-20
DE2516105C3 (de) 1982-01-07
IE40829L (en) 1975-10-19
BE828065A (fr) 1975-10-17
SE7503723L (sv) 1975-10-20
AR213271A1 (es) 1979-01-15
NL7504274A (nl) 1975-10-21
IL46994A0 (en) 1975-06-25
IL46994A (en) 1979-10-31
DK167075A (enExample) 1975-10-20
JPS50145515A (enExample) 1975-11-21
BG35326A3 (bg) 1984-03-15
ES436613A1 (es) 1977-04-16
FR2267760B1 (enExample) 1978-08-04
FI62220B (fi) 1982-08-31
DE2516105B2 (de) 1981-01-08
DE2516105A1 (de) 1975-10-23
DD119131A5 (enExample) 1976-04-12
ATA278875A (de) 1978-06-15
FI62220C (fi) 1982-12-10

Similar Documents

Publication Publication Date Title
AU539976B2 (en) Therapeutically active compounds
US3927197A (en) Tertiary alcohol stabilized E-series prostaglandins
GB1237278A (en) Herbicidal ester emulsions
IE38373L (en) N,n-dimethyl-o-triazolyl-carbamic acid esters; insecticides
IE40501B1 (en) Alkyl derivatives of prostanoic acids and preparation thereof
CA1262140C (en) 7-OXABICYCLOHEPTANE PROSTAGLANDIN SUBSTITUTE ALCOHOLS
ATE53295T1 (de) Arzneimittel die prostaglandin i2 enthalten.
GB1251750A (enExample)
GB1530154A (en) Prostaglandin analogues
GB1492439A (en) Prostaglandins
JPS5573678A (en) Simultated compound of thio-prostaglandin i1, its preparation and drug composition containing it as active ingredient
KR790000811B1 (ko) 안정화된 약제조성물의 제조방법
GB1499546A (en) Indolo-quinolizidine derivatives and a process for the preparation thereof
GB1202010A (en) Prostaglandins and the manufacture thereof
US4251463A (en) 2-Decarboxy-2-aminomethyl-9-deoxy-9-methylene-5,6-didehydro-PGF1 compounds
GB1437788A (en) Therapeutic compositions
US4041066A (en) 4,5-Cis-didehydro-PGE1 compounds
US4337337A (en) 2,5-Inter-o-phenylene-3,4-dinor-5,9α-epoxy-6-iodo-PGF1 compounds
US4638100A (en) Aromatic or inter-oxa 2-decarboxy-2-hydroxymethyl-PGFα compounds
US4328338A (en) 2,5-Inter-o-phenylene-3,4-dinor-6,9α-epoxy-6β-PGF1 amides
JPS57106644A (en) Farnesence derivative, mucosa stabilizer comprising it as active ingredient, and its preparation
GB1173577A (en) Improvements in or relating to New Indole Derivatives, Process for Preparing same and Therapeutic Compositions Containing them
ES432562A1 (es) Procedimiento para preparar esteres de acidos 2-exanofenil de tiofosforicos.
ES482971A1 (es) Procedimiento para la preparacion de nuevos derivados de prostaglandina en la serie a2-11-desoxi-pgf2 o pge2
ES394667A1 (es) Procedimiento de preparacion de derivados del acido prosta-noico.

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee